Co-Authors
This is a "connection" page, showing publications co-authored by Emily McDonald and Todd Lee.
Connection Strength
9.310
-
Ongoing Citations of a Retracted Study Involving Cardiovascular Disease, Drug Therapy, and Mortality in COVID-19. JAMA Intern Med. 2021 11 01; 181(11):1535-1537.
Score: 0.976
-
Tocilizumab versus the Covid19 tempest: All's well that ends well or much ado about nothing? Clin Microbiol Infect. 2021 02; 27(2):158-159.
Score: 0.905
-
Time-Series Analysis of Health Care-Associated Infections in a New Hospital With All Private Rooms. JAMA Intern Med. 2019 Nov 01; 179(11):1501-1506.
Score: 0.850
-
An online educational module on transfusion safety and appropriateness for resident physicians: a controlled before-after quality-improvement study. CMAJ Open. 2019 Jul-Sep; 7(3):E492-E496.
Score: 0.834
-
Hand hygiene "hall monitors": Leveraging the Hawthorne effect. Am J Infect Control. 2018 06; 46(6):706-707.
Score: 0.753
-
Inpatient Z-drug use commonly exceeds safe dosing recommendations. PLoS One. 2017; 12(5):e0177645.
Score: 0.717
-
Mindfulness-Based Laboratory Reduction: Reducing Utilization Through Trainee-Led Daily 'Time Outs'. Am J Med. 2017 06; 130(6):e241-e244.
Score: 0.703
-
Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2: A Systematic Review and Meta-analysis. JAMA Intern Med. 2021 03 01; 181(3):353-360.
Score: 0.233
-
Remdesivir and systemic corticosteroids for the treatment of COVID-19: A Bayesian re-analysis. Int J Infect Dis. 2021 Mar; 104:671-676.
Score: 0.232
-
An observational cohort study of hydroxychloroquine and azithromycin for COVID-19: (Can't Get No) Satisfaction. Int J Infect Dis. 2020 09; 98:216-217.
Score: 0.223
-
COVID-SAFER: Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults. J Am Geriatr Soc. 2020 Aug; 68(8):1636-1646.
Score: 0.222
-
Beta-Lactam/Beta-Lactamase Inhibitor Therapy for Potential AmpC-Producing Organisms: A Systematic Review and Meta-Analysis. Open Forum Infect Dis. 2019 Jul 01; 6(7).
Score: 0.208
-
Retrospective Cohort Study of the Prevalence of Off-label Gabapentinoid Prescriptions in Hospitalized Medical Patients. J Hosp Med. 2019 May 12; 14:E1-E4.
Score: 0.206
-
The Reply. Am J Med. 2019 01; 132(1):e24-e25.
Score: 0.201
-
Rates of Overtreatment and Treatment-Related Adverse Effects Among Patients With Subsegmental Pulmonary Embolism. JAMA Intern Med. 2018 Sep 01; 178(9):1272-1274.
Score: 0.196
-
MRSA colonization status as a predictor of clinical infection: A systematic review and meta-analysis. J Infect. 2018 12; 77(6):489-495.
Score: 0.195
-
Diastolic Hypotension May Attenuate Benefits from Intensive Systolic Targets: Secondary Analysis of a Randomized Controlled Trial. Am J Med. 2018 10; 131(10):1228-1233.e1.
Score: 0.193
-
Screening swabs surpass traditional risk factors as predictors of MRSA bacteremia. BMC Infect Dis. 2018 06 11; 18(1):270.
Score: 0.193
-
EMPOWERing Hospitalized Older Adults to Deprescribe Sedative Hypnotics: A Pilot Study. J Am Geriatr Soc. 2018 07; 66(6):1186-1189.
Score: 0.189
-
Rebound adrenal insufficiency after withdrawal of ritonavir in a 65-year-old man using inhaled budesonide. CMAJ. 2017 09 18; 189(37):E1188-E1191.
Score: 0.183
-
Missed Opportunities for Deprescription: A Teachable Moment. JAMA Intern Med. 2017 07 01; 177(7):1028-1029.
Score: 0.181
-
"Explainable" Weight Loss: A Teachable Moment. JAMA Intern Med. 2017 03 01; 177(3):420-421.
Score: 0.177
-
Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial. Clin Infect Dis. 2021 06 01; 72(11):e835-e843.
Score: 0.059
-
Lessons Learned From Conducting Internet-Based Randomized Clinical Trials During a Global Pandemic. Open Forum Infect Dis. 2021 Feb; 8(2):ofaa602.
Score: 0.058
-
Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19. Open Forum Infect Dis. 2020 Nov; 7(11):ofaa500.
Score: 0.057
-
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial. Ann Intern Med. 2020 10 20; 173(8):623-631.
Score: 0.056
-
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020 08 06; 383(6):517-525.
Score: 0.055
-
Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial. Can J Anaesth. 2020 09; 67(9):1201-1211.
Score: 0.055
-
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19). Open Forum Infect Dis. 2020 Apr; 7(4):ofaa130.
Score: 0.055
-
Evaluation of a Mobile Application to Enhance Medication Management Following Hospital Discharge: Study Protocol for a Pilot Randomized Controlled Trial. Stud Health Technol Inform. 2019 Aug 21; 264:1929-1930.
Score: 0.052
-
Association of Lower Diagnostic Yield With High Users of CT Pulmonary Angiogram. JAMA Intern Med. 2018 03 01; 178(3):412-413.
Score: 0.047
-
Proceedings of the Canadian Frailty Network Summit: Medication Optimization for Frail Older Canadians, Toronto, Monday April 24, 2017. Can Geriatr J. 2017 Dec; 20(4):253-263.
Score: 0.047